NCT04798898View on ClinicalTrials.gov

Improving Survival of COlorectal LIver Metastases by RFA-mediated Immunostimulation

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 14, 2022

Primary Completion Date

June 1, 2025

Study Completion Date

December 1, 2026

Conditions
Liver Metastasis Colon Cancer
Interventions
DEVICE

RFA (radiofrequency ablation)

Preoperative RFA-induced partial necrosis of the liver metastasis

Trial Locations (1)

8200

RECRUITING

Aarhus University Hospital, Department of Surgery, Aarhus

All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

lead

University of Aarhus

OTHER